Home The Word Brain	My Amedeo FAQ Privacy About
	Hanzi Hunter Learning 500 Chinese characters in 30 days is possible. Abstract • About

Alzheimer's Disease

Free Subscription Articles published in Acta Neuropathol Retrieve available abstracts of 106 articles: HTML format

Single Articles

February 2026
1. ONO D, Kondrakunta S, Mak E, Przybelski SA, et al
   Neuropathologic basis of quantitative susceptibility mapping in the substantia nigra: contributions of tau, pigmented neurons, and iron.
   Acta Neuropathol. 2026;151:17.
   PubMed     Abstract available
   
   
   January 2026
2. FERTAN E, Kedia S, Nolan G, Meisl G, et al
   Early synaptic pathology is associated with small tau aggregates in Alzheimer's disease.
   Acta Neuropathol. 2026;151:7.
   PubMed     Abstract available
   
   
   December 2025
3. MOHANTY R, Wheatley S, Chiotis K, Marseglia A, et al
   Distinct cerebrovascular pathways underlying Alzheimer's disease-related neurodegeneration.
   Acta Neuropathol. 2025;150:64.
   PubMed     Abstract available
   
   
   
4. TAYLOR LW, Simzer EM, Young LFP, Holt K, et al
   Confirmation of p-tau Ser356's association with Alzheimer's disease pathology and lowering in response to WZ4003 treatment in brain slice cultures. Reply to: "Phospho-tau Ser356 is mostly confined to pre-NFT neurons in Alzheimer's pathology".
   Acta Neuropathol. 2025;150:63.
   PubMed    
   
   
   
5. LE LTHL, Lee G, Shin JW, Shim YM, et al
   Phospho-tau Ser356 is mostly confined to pre-NFT neurons in Alzheimer's pathology.
   Acta Neuropathol. 2025;150:62.
   PubMed    
   
   
   
6. LIANG H, Hunt JB Jr, Ma C, Kovalenko A, et al
   Probing tau citrullination in Alzheimer's disease brains and mouse models of tauopathy.
   Acta Neuropathol. 2025;150:61.
   PubMed     Abstract available
   
   
   November 2025
7. IOANNOU K, Perrin RJ, Abdullaieva K, Bluma M, et al
   Neuropathologic correlates of cognitive impairment in Alzheimer's disease with discordant CSF biomarker profiles: co-pathologies in focus.
   Acta Neuropathol. 2025;150:57.
   PubMed     Abstract available
   
   
   
8. PHUONG HT, Tomas RF, Akmese C, Mijares A, et al
   PolyGR-containing aggregates link with pathology and clinical features of Alzheimer's disease.
   Acta Neuropathol. 2025;150:49.
   PubMed     Abstract available
   
   
   October 2025
9. NEUBAUER A, Weissenbrunner D, Pekrun S, Roeber S, et al
   Alpha-synuclein deposition patterns in Alzheimer's disease: association with cortical amyloid beta and variable tau load.
   Acta Neuropathol. 2025;150:46.
   PubMed     Abstract available
   
   
   
10. ZHANG Z, Capuano AW, Beadell A, Tasaki S, et al
    Brain-derived 5-hydroxymethylcytosine epigenetic scores are related to Alzheimer's disease pathology and cognitive decline.
    Acta Neuropathol. 2025;150:45.
    PubMed     Abstract available
    
    
    
11. AUGUR ZM, Fogo GM, Arbery MR, Hsieh YC, et al
    Genetic and proteomic analysis identifies BAG3 as an amyloid-responsive regulator of neuronal proteostasis.
    Acta Neuropathol. 2025;150:43.
    PubMed     Abstract available
    
    
    
12. INOUE Y, Wang H, Heckman MG, Ren Y, et al
    Impact of APOE on cerebrovascular lipid profile in Alzheimer's disease.
    Acta Neuropathol. 2025;150:39.
    PubMed     Abstract available
    
    
    September 2025
13. VAN WETERING J, Deshayes NAC, Boone J, Rodrigues Fernandes I, et al
    Limbic Alzheimer's co-pathology in multiple system atrophy is associated with cognitive impairment and diagnostic inaccuracy.
    Acta Neuropathol. 2025;150:30.
    PubMed     Abstract available
    
    
    
14. TOME SO, Gawor K, Ospitalieri S, Ronisz A, et al
    Differences and overlaps in TDP-43 pathology of 'pure' LATE-NC compared to LATE-NC coexisting with Alzheimer's disease.
    Acta Neuropathol. 2025;150:28.
    PubMed     Abstract available
    
    
    
15. OGG J, Postupna N, Gibbons LE, Ariza J, et al
    Down syndrome and a presenilin 2 variant: dual genetic risk of Alzheimer's disease.
    Acta Neuropathol. 2025;150:24.
    PubMed     Abstract available
    
    
    August 2025
16. NELSON PT, Crary JF
    PART and amyloid cascade hypotheses are alive and well (but are not so simple). Scientific commentary on: "Sequence and trajectory of early Alzheimer's disease-related tau inclusions in the hippocampal formation of cases without amyloid-beta deposits"
    Acta Neuropathol. 2025;150:14.
    PubMed    
    
    
    July 2025
17. MUKHERJEE S, Coyle R, Dubois C, Perez K, et al
    Isomerized Abeta in the brain can distinguish the status of amyloidosis in the Alzheimer's disease spectrum.
    Acta Neuropathol. 2025;150:7.
    PubMed     Abstract available
    
    
    
18. MARTINEZ-PEREZ DA, McGlothan JL, Rodichkin AN, Abilmouna K, et al
    Amyloid-beta plaque-associated microglia drive TSPO upregulation in Alzheimer's disease.
    Acta Neuropathol. 2025;150:6.
    PubMed     Abstract available
    
    
    June 2025
19. DOURTE M, Paitre E, Bouchoucha M, Boyer E, et al
    The olfactory epithelium: a critical gateway for pathological tau propagation and a target for mitigating tauopathy in the central nervous system.
    Acta Neuropathol. 2025;149:64.
    PubMed     Abstract available
    
    
    
20. CHEN CD, Franklin EE, Li Y, Joseph-Mathurin N, et al
    Immunohistochemical evaluation of a trial of gantenerumab or solanezumab in dominantly inherited Alzheimer disease.
    Acta Neuropathol. 2025;149:57.
    PubMed     Abstract available
    
    
    
21. ONDREJCAK T, Hu NW, Coode E, Campbell T, et al
    Synaptotoxic effects of extracellular tau are mediated by its microtubule-binding region.
    Acta Neuropathol. 2025;149:56.
    PubMed     Abstract available
    
    
    
22. LIAO F, Calvo-Rodriguez M, Chhaya M, Sefrin JP, et al
    Anti-pyroglutamate-3 Abeta immunotherapy engages microglia and inhibits amyloid accumulation in transgenic mouse models of Abeta amyloidosis.
    Acta Neuropathol. 2025;149:55.
    PubMed     Abstract available
    
    
    May 2025
23. SADLEIR KR, Gomez KP, Edwards AE, Patel AJ, et al
    Annexin A6 membrane repair protein protects against amyloid-induced dystrophic neurites and tau phosphorylation in Alzheimer's disease model mice.
    Acta Neuropathol. 2025;149:51.
    PubMed     Abstract available
    
    
    
24. BRAAK H, Mayer B, Feldengut S, Schon M, et al
    Sequence and trajectory of early Alzheimer's disease-related tau inclusions in the hippocampal formation of cases without amyloid-beta deposits.
    Acta Neuropathol. 2025;149:50.
    PubMed     Abstract available
    
    
    
25. FARRELL C, Buhidma Y, Mumford P, Heywood WE, et al
    Apolipoprotein E abundance is elevated in the brains of individuals with Down syndrome-Alzheimer's disease.
    Acta Neuropathol. 2025;149:49.
    PubMed     Abstract available
    
    
    
26. KAVANAGH T, Thierry M, Balcomb K, Ponce J, et al
    The interactome of tau phosphorylated at T217 in Alzheimer's disease human brain tissue.
    Acta Neuropathol. 2025;149:44.
    PubMed     Abstract available
    
    
    April 2025
27. LANTERO-RODRIGUEZ J, Montoliu-Gaya L, Benedet AL, Vrillon A, et al
    Correction: CSF p-tau205: a biomarker of tau pathology in Alzheimer's disease.
    Acta Neuropathol. 2025;149:34.
    PubMed    
    
    
    
28. FELEKE R, Jogaudaite S, Velentza-Almpani E, Yeung-Yeung L, et al
    Seeding-competent early tau multimers are associated with cell type-specific transcriptional signatures.
    Acta Neuropathol. 2025;149:31.
    PubMed     Abstract available
    
    
    March 2025
29. LANTERO-RODRIGUEZ J, Montoliu-Gaya L, Ashton NJ, Pola I, et al
    Biofluid-based staging of Alzheimer's disease.
    Acta Neuropathol. 2025;149:27.
    PubMed     Abstract available
    
    
    
30. GHATAMANENI S, Hruska C, Shin I, Bruinsma T, et al
    High resolution autoradiography of [(18)F]MK-6240 and [(18)F]Flortaucipir shows similar neurofibrillary tangle binding patterns preferentially recognizing middling neurofibrillary tangle maturity.
    Acta Neuropathol. 2025;149:26.
    PubMed     Abstract available
    
    
    February 2025
31. EBNER BA, Erdahl SA, Lundgreen CS, Vassilaki M, et al
    Brain tissue metal concentrations and Alzheimer's disease neuropathology in total joint arthroplasty patients versus controls.
    Acta Neuropathol. 2025;149:18.
    PubMed     Abstract available
    
    
    
32. FIXEMER S, Miranda de la Maza M, Hammer GP, Jeannelle F, et al
    Microglia aggregates define distinct immune and neurodegenerative niches in Alzheimer's disease hippocampus.
    Acta Neuropathol. 2025;149:19.
    PubMed     Abstract available
    
    
    January 2025
33. MARTA-ARIZA M, Leitner DF, Kanshin E, Suazo J, et al
    Comparison of the amyloid plaque proteome in Down syndrome, early-onset Alzheimer's disease, and late-onset Alzheimer's disease.
    Acta Neuropathol. 2025;149:9.
    PubMed     Abstract available
    
    
    
34. SAEZ-CALVERAS N, Vaquer-Alicea J, White CL 3rd, Tak Y, et al
    Essential tremor with tau pathology features seeds indistinguishable in conformation from Alzheimer's disease and primary age-related tauopathy.
    Acta Neuropathol. 2025;149:6.
    PubMed     Abstract available
    
    
    December 2024
35. MOONEN S, Koper MJ, Van Schoor E, Schaeverbeke JM, et al
    Correction: Pyroptosis in Alzheimer's disease: cell type?specific activation in microglia, astrocytes and neurons.
    Acta Neuropathol. 2024;149:3.
    PubMed    
    
    
    
36. KADAMANGUDI S, Marcatti M, Zhang WR, Fracassi A, et al
    Amyloid-beta oligomers increase the binding and internalization of tau oligomers in human synapses.
    Acta Neuropathol. 2024;149:2.
    PubMed     Abstract available
    
    
    
37. SCHREMPEL S, Kottwitz AK, Piechotta A, Gnoth K, et al
    Identification of isoAsp7-Abeta as a major Abeta variant in Alzheimer's disease, dementia with Lewy bodies and vascular dementia.
    Acta Neuropathol. 2024;148:78.
    PubMed     Abstract available
    
    
    November 2024
38. ROY N, Haq I, Ngo JC, Bennett DA, et al
    Elevated expression of the retrotransposon LINE-1 drives Alzheimer's disease-associated microglial dysfunction.
    Acta Neuropathol. 2024;148:75.
    PubMed     Abstract available
    
    
    
39. BALCOMB K, Johnston C, Kavanagh T, Leitner D, et al
    SMOC1 colocalizes with Alzheimer's disease neuropathology and delays Abeta aggregation.
    Acta Neuropathol. 2024;148:72.
    PubMed     Abstract available
    
    
    
40. PHILLIPS JM, Winfree RL, Seto M, Schneider JA, et al
    Pathologic and clinical correlates of region-specific brain GFAP in Alzheimer's disease.
    Acta Neuropathol. 2024;148:69.
    PubMed     Abstract available
    
    
    
41. KATSUMATA Y, Wu X, Aung KZ, Fardo DW, et al
    Pure LATE-NC: Frequency, clinical impact, and the importance of considering APOE genotype when assessing this and other subtypes of non-Alzheimer's pathologies.
    Acta Neuropathol. 2024;148:66.
    PubMed     Abstract available
    
    
    
42. GARLAND EF, Antony H, Kulagowska L, Scott T, et al
    The microglial translocator protein (TSPO) in Alzheimer's disease reflects a phagocytic phenotype.
    Acta Neuropathol. 2024;148:62.
    PubMed     Abstract available
    
    
    October 2024
43. VATTATHIL SM, Tan SSM, Kim PJ, Bennett DA, et al
    Effects of brain microRNAs in cognitive trajectory and Alzheimer's disease.
    Acta Neuropathol. 2024;148:59.
    PubMed     Abstract available
    
    
    
44. SHANAKI BAVARSAD M, Spina S, Oehler A, Allen IE, et al
    Comprehensive mapping of synaptic vesicle protein 2A (SV2A) in health and neurodegenerative diseases: a comparative analysis with synaptophysin and ground truth for PET-imaging interpretation.
    Acta Neuropathol. 2024;148:58.
    PubMed     Abstract available
    
    
    
45. WANG YR, Zeng XQ, Wang J, Fowler CJ, et al
    Autoantibodies to BACE1 promote Abeta accumulation and neurodegeneration in Alzheimer's disease.
    Acta Neuropathol. 2024;148:57.
    PubMed     Abstract available
    
    
    
46. LAUREYSSEN C, Kucukali F, Van Dongen J, Gawor K, et al
    Hypothesis-based investigation of known AD risk variants reveals the genetic underpinnings of neuropathological lesions observed in Alzheimer's-type dementia.
    Acta Neuropathol. 2024;148:55.
    PubMed     Abstract available
    
    
    September 2024
47. GIONG HK, Hyeon SJ, Lee JG, Cho HJ, et al
    Tau accumulation is cleared by the induced expression of VCP via autophagy.
    Acta Neuropathol. 2024;148:46.
    PubMed     Abstract available
    
    
    
48. FREIBURGHAUS T, Pawlik D, Oliveira Hauer K, Ossenkoppele R, et al
    Association of in vivo retention of [(18)f] flortaucipir pet with tau neuropathology in corresponding brain regions.
    Acta Neuropathol. 2024;148:44.
    PubMed     Abstract available
    
    
    
49. DENNING AE, Ittyerah R, Levorse LM, Sadeghpour N, et al
    Association of quantitative histopathology measurements with antemortem medial temporal lobe cortical thickness in the Alzheimer's disease continuum.
    Acta Neuropathol. 2024;148:37.
    PubMed     Abstract available
    
    
    August 2024
50. SCHRODER S, Fuchs U, Gisa V, Pena T, et al
    PRDM16-DT is a novel lncRNA that regulates astrocyte function in Alzheimer's disease.
    Acta Neuropathol. 2024;148:32.
    PubMed     Abstract available
    
    
    
51. BOTELLA LUCENA P, Heneka MT
    Inflammatory aspects of Alzheimer's disease.
    Acta Neuropathol. 2024;148:31.
    PubMed     Abstract available
    
    
    
52. MA Y, Reyes-Dumeyer D, Piriz A, Recio P, et al
    Epigenetic and genetic risk of Alzheimer disease from autopsied brains in two ethnic groups.
    Acta Neuropathol. 2024;148:27.
    PubMed     Abstract available
    
    
    
53. HART DE RUYTER FJ, Evers MJAP, Morrema THJ, Dijkstra AA, et al
    Neuropathological hallmarks in the post-mortem retina of neurodegenerative diseases.
    Acta Neuropathol. 2024;148:24.
    PubMed     Abstract available
    
    
    
54. HOQ MR, Fernandez A, Vago FS, Hallinan GI, et al
    Cryo-EM structures of cotton wool plaques' amyloid beta and of tau filaments in dominantly inherited Alzheimer disease.
    Acta Neuropathol. 2024;148:20.
    PubMed     Abstract available
    
    
    
55. JURY-GARFE N, Redding-Ochoa J, You Y, Martinez P, et al
    Enhanced microglial dynamics and a paucity of tau seeding in the amyloid plaque microenvironment contribute to cognitive resilience in Alzheimer's disease.
    Acta Neuropathol. 2024;148:15.
    PubMed     Abstract available
    
    
    July 2024
56. LEITNER D, Kavanagh T, Kanshin E, Balcomb K, et al
    Differences in the cerebral amyloid angiopathy proteome in Alzheimer's disease and mild cognitive impairment.
    Acta Neuropathol. 2024;148:9.
    PubMed     Abstract available
    
    
    
57. KASRI A, Camporesi E, Gkanatsiou E, Boluda S, et al
    Amyloid-beta peptide signature associated with cerebral amyloid angiopathy in familial Alzheimer's disease with APPdup and Down syndrome.
    Acta Neuropathol. 2024;148:8.
    PubMed     Abstract available
    
    
    
58. SHI H, Mirzaei N, Koronyo Y, Davis MR, et al
    Identification of retinal oligomeric, citrullinated, and other tau isoforms in early and advanced AD and relations to disease status.
    Acta Neuropathol. 2024;148:3.
    PubMed     Abstract available
    
    
    June 2024
59. QU W, Lam M, McInvale JJ, Mares JA, et al
    Xenografted human iPSC-derived neurons with the familial Alzheimer's disease APP(V717I) mutation reveal dysregulated transcriptome signatures linked to synaptic function and implicate LINGO2 as a disease signaling mediator.
    Acta Neuropathol. 2024;147:107.
    PubMed     Abstract available
    
    
    
60. OLLEN-BITTLE N, Pejhan S, Pasternak SH, Keene CD, et al
    Co-registration of MALDI-MSI and histology demonstrates gangliosides co-localize with amyloid beta plaques in Alzheimer's disease.
    Acta Neuropathol. 2024;147:105.
    PubMed     Abstract available
    
    
    
61. WOODWORTH DC, Nguyen KM, Sordo L, Scambray KA, et al
    Comprehensive assessment of TDP-43 neuropathology data in the National Alzheimer's Coordinating Center database.
    Acta Neuropathol. 2024;147:103.
    PubMed     Abstract available
    
    
    
62. HOGLUND Z, Ruiz-Uribe N, Del Sastre E, Woost B, et al
    Brain vasculature accumulates tau and is spatially related to tau tangle pathology in Alzheimer's disease.
    Acta Neuropathol. 2024;147:101.
    PubMed     Abstract available
    
    
    
63. SARKANY B, David C, Hortobagyi T, Gombas P, et al
    Early and selective localization of tau filaments to glutamatergic subcellular domains within the human anterodorsal thalamus.
    Acta Neuropathol. 2024;147:98.
    PubMed     Abstract available
    
    
    
64. GAO F, Zhang M, Wang Q, Ni M, et al
    Associations of CSF BACE1 with amyloid pathology, neurodegeneration, and cognition in Alzheimer's disease.
    Acta Neuropathol. 2024;147:97.
    PubMed     Abstract available
    
    
    
65. BALUSU S, De Strooper B
    The necroptosis cell death pathway drives neurodegeneration in Alzheimer's disease.
    Acta Neuropathol. 2024;147:96.
    PubMed     Abstract available
    
    
    
66. ANDO K, Kucukali F, Doeraene E, Nagaraj S, et al
    Alteration of gene expression and protein solubility of the PI 5-phosphatase SHIP2 are correlated with Alzheimer's disease pathology progression.
    Acta Neuropathol. 2024;147:94.
    PubMed     Abstract available
    
    
    May 2024
67. GRANHOLM AE, Englund E, Gilmore A, Head E, et al
    Neuropathological findings in Down syndrome, Alzheimer's disease and control patients with and without SARS-COV-2: preliminary findings.
    Acta Neuropathol. 2024;147:92.
    PubMed     Abstract available
    
    
    
68. THIERRY M, Ponce J, Marta-Ariza M, Askenazi M, et al
    The influence of APOE(epsilon4) on the pTau interactome in sporadic Alzheimer's disease.
    Acta Neuropathol. 2024;147:91.
    PubMed     Abstract available
    
    
    
69. ELLIS MJ, Lekka C, Holden KL, Tulmin H, et al
    Identification of high-performing antibodies for the reliable detection of Tau proteoforms by Western blotting and immunohistochemistry.
    Acta Neuropathol. 2024;147:87.
    PubMed     Abstract available
    
    
    
70. FANCY NN, Smith AM, Caramello A, Tsartsalis S, et al
    Characterisation of premature cell senescence in Alzheimer's disease using single nuclear transcriptomics.
    Acta Neuropathol. 2024;147:78.
    PubMed     Abstract available
    
    
    April 2024
71. BHATTARAI P, Gunasekaran TI, Belloy ME, Reyes-Dumeyer D, et al
    Rare genetic variation in fibronectin 1 (FN1) protects against APOEepsilon4 in Alzheimer's disease.
    Acta Neuropathol. 2024;147:70.
    PubMed     Abstract available
    
    
    
72. THAL DR, Gawor K, Moonen S
    Regulated cell death and its role in Alzheimer's disease and amyotrophic lateral sclerosis.
    Acta Neuropathol. 2024;147:69.
    PubMed     Abstract available
    
    
    
73. JAISA-AAD M, Munoz-Castro C, Healey MA, Hyman BT, et al
    Characterization of monoamine oxidase-B (MAO-B) as a biomarker of reactive astrogliosis in Alzheimer's disease and related dementias.
    Acta Neuropathol. 2024;147:66.
    PubMed     Abstract available
    
    
    
74. WACHTER A, Woodbury ME, Lombardo S, Abdourahman A, et al
    Landscape of brain myeloid cell transcriptome along the spatiotemporal progression of Alzheimer's disease reveals distinct sequential responses to Abeta and tau.
    Acta Neuropathol. 2024;147:65.
    PubMed     Abstract available
    
    
    March 2024
75. BOUTER Y, Noguerola JSL, Tucholla P, Crespi GAN, et al
    Correction: Abeta targets of the biosimilar antibodies of Bapineuzumab, Crenezumab, Solanezumab in comparison to an antibody against N-truncted Abeta in sporadic Alzheimer disease cases and mouse models.
    Acta Neuropathol. 2024;147:59.
    PubMed    
    
    
    
76. MALDONADO-DIAZ C, Hiya S, Yokoda RT, Farrell K, et al
    Disentangling and quantifying the relative cognitive impact of concurrent mixed neurodegenerative pathologies.
    Acta Neuropathol. 2024;147:58.
    PubMed     Abstract available
    
    
    
77. XU H, Qiu Q, Hu P, Hoxha K, et al
    MSUT2 regulates tau spreading via adenosinergic signaling mediated ASAP1 pathway in neurons.
    Acta Neuropathol. 2024;147:55.
    PubMed     Abstract available
    
    
    
78. WALTON RL, Koga S, Beasley AI, White LJ, et al
    Role of GBA variants in Lewy body disease neuropathology.
    Acta Neuropathol. 2024;147:54.
    PubMed     Abstract available
    
    
    February 2024
79. ALEXANDER A, Alvarez VE, Huber BR, Alosco ML, et al
    Cortical-sparing chronic traumatic encephalopathy (CSCTE): a distinct subtype of CTE.
    Acta Neuropathol. 2024;147:45.
    PubMed     Abstract available
    
    
    
80. MALIK N, Miah MU, Galgani A, McAleese K, et al
    Regional AT-8 reactive tau species correlate with intracellular Abeta levels in cases of low AD neuropathologic change.
    Acta Neuropathol. 2024;147:40.
    PubMed     Abstract available
    
    
    
81. WU YC, Bogale TA, Koistinaho J, Pizzi M, et al
    The contribution of beta-amyloid, Tau and alpha-synuclein to blood-brain barrier damage in neurodegenerative disorders.
    Acta Neuropathol. 2024;147:39.
    PubMed     Abstract available
    
    
    
82. COLOM-CADENA M, Toombs J, Simzer E, Holt K, et al
    Transmembrane protein 97 is a potential synaptic amyloid beta receptor in human Alzheimer's disease.
    Acta Neuropathol. 2024;147:32.
    PubMed     Abstract available
    
    
    
83. OERTEL FC, Casillas D, Cobigo Y, Condor Montes S, et al
    Scientific commentary on: "Phosphorylated tau in the retina correlates with tau pathology in the brain in Alzheimer's disease and primary tauopathies".
    Acta Neuropathol. 2024;147:30.
    PubMed    
    
    
    
84. CHUNG M, Carter EK, Veire AM, Dammer EB, et al
    Cryptic exon inclusion is a molecular signature of LATE-NC in aging brains.
    Acta Neuropathol. 2024;147:29.
    PubMed     Abstract available
    
    
    January 2024
85. LEITNER D, Pires G, Kavanagh T, Kanshin E, et al
    Similar brain proteomic signatures in Alzheimer's disease and epilepsy.
    Acta Neuropathol. 2024;147:27.
    PubMed     Abstract available
    
    
    
86. AGUERO C, Dhaynaut M, Amaral AC, Moon SH, et al
    Head-to-head comparison of [(18)F]-Flortaucipir, [(18)F]-MK-6240 and [(18)F]-PI-2620 postmortem binding across the spectrum of neurodegenerative diseases.
    Acta Neuropathol. 2024;147:25.
    PubMed     Abstract available
    
    
    
87. FAZELI E, Child DD, Bucks SA, Stovarsky M, et al
    A familial missense variant in the Alzheimer's disease gene SORL1 impairs its maturation and endosomal sorting.
    Acta Neuropathol. 2024;147:20.
    PubMed     Abstract available
    
    
    
88. VAN DER GAAG BL, Deshayes NAC, Breve JJP, Bol JGJM, et al
    Distinct tau and alpha-synuclein molecular signatures in Alzheimer's disease with and without Lewy bodies and Parkinson's disease with dementia.
    Acta Neuropathol. 2024;147:14.
    PubMed     Abstract available
    
    
    
89. LANTERO-RODRIGUEZ J, Montoliu-Gaya L, Benedet AL, Vrillon A, et al
    CSF p-tau205: a biomarker of tau pathology in Alzheimer's disease.
    Acta Neuropathol. 2024;147:12.
    PubMed     Abstract available
    
    
    
90. AGRA ALMEIDA QUADROS AR, Li Z, Wang X, Ndayambaje IS, et al
    Cryptic splicing of stathmin-2 and UNC13A mRNAs is a pathological hallmark of TDP-43-associated Alzheimer's disease.
    Acta Neuropathol. 2024;147:9.
    PubMed     Abstract available
    
    
    
91. TAYLOR LW, Simzer EM, Pimblett C, Lacey-Solymar OTT, et al
    p-tau Ser356 is associated with Alzheimer's disease pathology and is lowered in brain slice cultures using the NUAK inhibitor WZ4003.
    Acta Neuropathol. 2024;147:7.
    PubMed     Abstract available
    
    
    December 2023
92. MONTOLIU-GAYA L, Alosco ML, Yhang E, Tripodis Y, et al
    Optimal blood tau species for the detection of Alzheimer's disease neuropathology: an immunoprecipitation mass spectrometry and autopsy study.
    Acta Neuropathol. 2023;147:5.
    PubMed     Abstract available
    
    
    
93. CHANG K, Ling JP, Redding-Ochoa J, An Y, et al
    Loss of TDP-43 splicing repression occurs early in the aging population and is associated with Alzheimer's disease neuropathologic changes and cognitive decline.
    Acta Neuropathol. 2023;147:4.
    PubMed     Abstract available
    
    
    November 2023
94. VANDEVREDE L, La Joie R, Horiki S, Mundada NS, et al
    Co-pathology may impact outcomes of amyloid-targeting treatments: clinicopathological results from two patients treated with aducanumab.
    Acta Neuropathol. 2023;146:777-781.
    PubMed    
    
    
    September 2023
95. SORDO L, Qian T, Bukhari SA, Nguyen KM, et al
    Characterization of hippocampal sclerosis of aging and its association with other neuropathologic changes and cognitive deficits in the oldest-old.
    Acta Neuropathol. 2023;146:415-432.
    PubMed     Abstract available
    
    
    August 2023
96. NGUYEN AT, Wang K, Hu G, Wang X, et al
    Correction: APOE and TREM2 regulate amyloid-responsive microglia in Alzheimer's disease.
    Acta Neuropathol. 2023 Aug 17. doi: 10.1007/s00401-023-02620.
    PubMed    
    
    
    
97. JUDD JM, Jasbi P, Winslow W, Serrano GE, et al
    Inflammation and the pathological progression of Alzheimer's disease are associated with low circulating choline levels.
    Acta Neuropathol. 2023 Aug 7. doi: 10.1007/s00401-023-02616.
    PubMed     Abstract available
    
    
    
98. MATE DE GERANDO A, Welikovitch LA, Khasnavis A, Commins C, et al
    Tau seeding and spreading in vivo is supported by both AD-derived fibrillar and oligomeric tau.
    Acta Neuropathol. 2023;146:191-210.
    PubMed     Abstract available
    
    
    July 2023
99. NEUMANN M, Perneel J, Cheung S, Van den Broeck M, et al
    Limbic-predominant age-related TDP-43 proteinopathy (LATE-NC) is associated with abundant TMEM106B pathology.
    Acta Neuropathol. 2023;146:163-166.
    PubMed    
    
    
    
100. YU L, Boyle PA, Janelidze S, Petyuk VA, et al
     Plasma p-tau181 and p-tau217 in discriminating PART, AD and other key neuropathologies in older adults.
     Acta Neuropathol. 2023;146:1-11.
     PubMed     Abstract available
     
     
     June 2023
101. BERMUDEZ C, Graff-Radford J, Syrjanen JA, Stricker NH, et al
     Plasma biomarkers for prediction of Alzheimer's disease neuropathologic change.
     Acta Neuropathol. 2023 Jun 3. doi: 10.1007/s00401-023-02594.
     PubMed     Abstract available
     
     
     
102. FILIPELLO F, You SF, Mirfakhar FS, Mahali S, et al
     Defects in lysosomal function and lipid metabolism in human microglia harboring a TREM2 loss of function mutation.
     Acta Neuropathol. 2023;145:749-772.
     PubMed     Abstract available
     
     
     May 2023
103. MANCA M, Standke HG, Browne DF, Huntley ML, et al
     Tau seeds occur before earliest Alzheimer's changes and are prevalent across neurodegenerative diseases.
     Acta Neuropathol. 2023 May 8. doi: 10.1007/s00401-023-02574.
     PubMed     Abstract available
     
     
     
104. HOQ MR, Bharath SR, Hallinan GI, Fernandez A, et al
     Cross-beta helical filaments of Tau and TMEM106B in gray and white matter of multiple system tauopathy with presenile dementia.
     Acta Neuropathol. 2023;145:707-710.
     PubMed    
     
     
     March 2023
105. CHENG Y, He CY, Tian DY, Chen SH, et al
     Physiological beta-amyloid clearance by the liver and its therapeutic potential for Alzheimer's disease.
     Acta Neuropathol. 2023 Mar 25. doi: 10.1007/s00401-023-02559.
     PubMed     Abstract available
     
     
     
106. WINFREE RL, Seto M, Dumitrescu L, Menon V, et al
     TREM2 gene expression associations with Alzheimer's disease neuropathology are region-specific: implications for cortical versus subcortical microglia.
     Acta Neuropathol. 2023 Mar 25. doi: 10.1007/s00401-023-02564.
     PubMed     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Alzheimer's Disease is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum